Comparative Effectiveness of Oral Anticoagulants: A Cohort Study

Study identification

• EU PAS number:
  EUPAS3061
• Study ID:
  9417
• Official title and acronym:
  Comparative Effectiveness of Oral Anticoagulants: A Cohort Study
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  This cohort study plans to identify initiators of oral anticoagulants using electronic claims data from a commercial insurance database to quantify associations between anticoagulant choice (warfarin and dabigatran) and the occurrence of selected outcomes in patients with non-valvular atrial fibrillation at risk for stroke.
• Study status:
  Finalised

Research institutions and networks

Institutions

Brigham and Women's Hospital

Study timelines

Date when funding contract was signed

Planned:01/06/2012

Actual:01/06/2012

Study start date

Planned:18/04/2013

Actual:17/04/2013

Data analysis start date

Planned:22/04/2013

Actual:22/04/2013

Date of final study report

Planned:30/09/2013

Actual:14/04/2014

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Boehringer Ingelheim

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

1160.157
NCT01847547